Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
Open Access
- 21 February 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (13) , 16146-16157
Abstract
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomasKeywords
This publication has 45 references indexed in Scilit:
- Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma ModelNeoplasia, 2015
- Role of Angiopoietin-2 in Adaptive Tumor Resistance to VEGF Signaling BlockadeCell Reports, 2014
- Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastomaNeuro-Oncology, 2013
- Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor TherapyCancer Research, 2013
- Biomarkers of response and resistance to antiangiogenic therapyNature Reviews Clinical Oncology, 2009
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent GlioblastomaJournal of Clinical Oncology, 2009
- VEGF Trap induces antiglioma effect at different stages of diseaseNeuro-Oncology, 2008
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and InvasionCancer Cell, 2008
- Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsCancer Cell, 2005
- Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2Proceedings of the National Academy of Sciences, 1998